Protein FDR Confidence: Combined	Accession	Description	Exp. q-value: Combined	Sum PEP Score	Coverage [%]	# Peptides	# PSMs	# Unique Peptides	# AAs	MW [kDa]	calc. pI	Abundance Ratio: (B Stem KO) / (B Stem WT)	Abundance Ratio (log2): (B Stem KO) / (B Stem WT)	Abundance Ratio P-Value: (B Stem KO) / (B Stem WT)	Abundance Ratio Adj. P-Value: (B Stem KO) / (B Stem WT)	Abundance Ratio Variability [%]: (B Stem KO) / (B Stem WT)	Abundances (Grouped): B Stem KO	Abundances (Grouped): B Stem WT	Abundances (Grouped) CV [%]: B Stem KO	Abundances (Grouped) CV [%]: B Stem WT	Abundances (Scaled): F2: 129, Sample, B Stem KO, 1	Abundances (Scaled): F2: 130, Sample, B Stem KO, 2	Abundances (Scaled): F2: 131, Sample, B Stem KO, 3	Abundances (Scaled): F2: 126, Sample, B Stem WT, 1	Abundances (Scaled): F2: 127, Sample, B Stem WT, 2	Abundances (Scaled): F2: 128, Sample, B Stem WT, 3	Abundances (Normalized): F2: 129, Sample, B Stem KO, 1	Abundances (Normalized): F2: 130, Sample, B Stem KO, 2	Abundances (Normalized): F2: 131, Sample, B Stem KO, 3	Abundances (Normalized): F2: 126, Sample, B Stem WT, 1	Abundances (Normalized): F2: 127, Sample, B Stem WT, 2	Abundances (Normalized): F2: 128, Sample, B Stem WT, 3	Abundance: F2: 129, Sample, B Stem KO, 1	Abundance: F2: 130, Sample, B Stem KO, 2	Abundance: F2: 131, Sample, B Stem KO, 3	Abundance: F2: 126, Sample, B Stem WT, 1	Abundance: F2: 127, Sample, B Stem WT, 2	Abundance: F2: 128, Sample, B Stem WT, 3	Abundances Count: F2: 129, Sample, B Stem KO, 1	Abundances Count: F2: 130, Sample, B Stem KO, 2	Abundances Count: F2: 131, Sample, B Stem KO, 3	Abundances Count: F2: 126, Sample, B Stem WT, 1	Abundances Count: F2: 127, Sample, B Stem WT, 2	Abundances Count: F2: 128, Sample, B Stem WT, 3	Biological Process	Cellular Component	Molecular Function	Pfam IDs	Entrez Gene ID	Gene Symbol	Chromosome	Reactome Pathways	Ensembl Gene ID	KEGG Pathways	WikiPathways	# Razor Peptides	Modifications
High	P62806	Histone H4 OS=Mus musculus OX=10090 GN=H4c1 PE=1 SV=2	0	26.288	51	5	9	5	103	11.4	11.36	1.091	0.13	0.439277789	0.964910683	17.81	110.8	89.2	32.73	24.41	147.6	108.1	75.4	87	112.7	69.2	898	657.8	459	529.1	685.5	420.9	785.8	625.9	459	467.5	640.6	406.3	4	4	4	4	4	4	cell organization and biogenesis;metabolic process;regulation of biological process	chromosome;membrane;nucleus	DNA binding;protein binding;RNA binding	"Pf00125, Pf02969, Pf15630"	320332; 326619; 319160; 319155; 319158; 319161; 69386; 319157; 319159; 326620; 100041230; 319156; 97122; 102641229	Hist4h4; Hist1h4a; Hist1h4k; Hist1h4c; Hist1h4i; Hist1h4n; Hist1h4h; Hist1h4f; Hist1h4j; Hist1h4b; Hist1h4m; Hist1h4d; Hist2h4; LOC100862646; LOC102641229	6; 13; 3	Transcriptional regulation by small RNAs; RUNX1 regulates transcription of genes involved in differentiation of HSCs; HATs acetylate histones; Meiotic Recombination; HDMs demethylate histones; Deposition of new CENPA-containing nucleosomes at the centromere; Formation of the beta-catenin:TCF transactivating complex; PRC2 methylates histones and DNA; SUMOylation of chromatin organization proteins; Nonhomologous End-Joining (NHEJ); RMTs methylate histone arginines; NoRC negatively regulates rRNA expression; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3; Oxidative Stress Induced Senescence; Senescence-Associated Secretory Phenotype (SASP); DNA Damage/Telomere Stress Induced Senescence; SIRT1 negatively regulates rRNA expression; Condensation of Prophase Chromosomes; B-WICH complex positively regulates rRNA expression; RNA Polymerase I Promoter Opening; NoRC negatively regulates rRNA expression; Meiotic Synapsis; G2/M DNA damage checkpoint; PKMTs methylate histone lysines; Mus musculus biological processes; RNA Polymerase I Chain Elongation	ENSMUSG00000096010.2; ENSMUSG00000091405.2; ENSMUSG00000060981.6; ENSMUSG00000069274.3; ENSMUSG00000061482.6; ENSMUSG00000067455.5; ENSMUSG00000064288.4; ENSMUSG00000060678.4; ENSMUSG00000069306.5; ENSMUSG00000069305.3; ENSMUSG00000069266.5; ENSMUSG00000060093.6; ENSMUSG00000060639.5	Alcoholism; Systemic lupus erythematosus; Viral carcinogenesis	Type II interferon signaling (IFNG)	0

[View entry in the full dataset]